Candriam S.C.A. G1 Therapeutics, Inc. Transaction History

Candriam S.C.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 19, 2020	SELL	$11.55 - $23.75 $10.1 Million - $20.7 Million	-870,423 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$9.57 - $24.37 $4.88 Million - $12.4 Million	510,014 Added 141.51%	870,423 $21.1 Million
Q1 2020 May 26, 2020	BUY	$9.07 - $26.32 $199 - $579	22 Added 0.01%	360,409 $9.31 Million
Q4 2019 Jan 21, 2020	BUY	$20.54 - $31.0 $1.19 Million - $1.79 Million	57,887 Added 19.14%	360,387 $10,000
Q3 2019 Oct 21, 2019	BUY	$22.78 - $40.58 $6.89 Million - $12.3 Million	302,500 New	302,500 $7,000

3.71M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.